(Total Views: 590)
Posted On: 03/04/2022 3:16:37 PM
Post# of 153905
It is now 2 months since CytoDyn was going to report the 700 NASH numbers. This affects the share price.
The Brazil trial was scheduled to finish in February which came and went. Are there results. This affects the share price.
Same for HIV/BLA and mTNBC. They affect the share price.
"In a timely manner" is up for discussion, but when you get rid of the CEO and there is NO reason given, that affects the share price.
You don't need to put out a PR, just contact one of the members of this board and we can PM each other. My last 5 months has been an advocate for Leronlimab for Long Haulers and we have been completely left out in the cold.
The Brazil trial was scheduled to finish in February which came and went. Are there results. This affects the share price.
Same for HIV/BLA and mTNBC. They affect the share price.
"In a timely manner" is up for discussion, but when you get rid of the CEO and there is NO reason given, that affects the share price.
You don't need to put out a PR, just contact one of the members of this board and we can PM each other. My last 5 months has been an advocate for Leronlimab for Long Haulers and we have been completely left out in the cold.
(3)
(3)
